These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19535621)

  • 1. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease.
    Andoh A; Shioya M; Nishida A; Bamba S; Tsujikawa T; Kim-Mitsuyama S; Fujiyama Y
    J Immunol; 2009 Jul; 183(1):687-95. PubMed ID: 19535621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts.
    Andoh A; Zhang Z; Inatomi O; Fujino S; Deguchi Y; Araki Y; Tsujikawa T; Kitoh K; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y
    Gastroenterology; 2005 Sep; 129(3):969-84. PubMed ID: 16143135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
    Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
    J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis.
    Kobori A; Yagi Y; Imaeda H; Ban H; Bamba S; Tsujikawa T; Saito Y; Fujiyama Y; Andoh A
    J Gastroenterol; 2010 Oct; 45(10):999-1007. PubMed ID: 20405148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial expression of interleukin-37b in inflammatory bowel disease.
    Imaeda H; Takahashi K; Fujimoto T; Kasumi E; Ban H; Bamba S; Sonoda H; Shimizu T; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2013 Jun; 172(3):410-6. PubMed ID: 23600829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts.
    Takahashi K; Imaeda H; Fujimoto T; Ban H; Bamba S; Tsujikawa T; Sasaki M; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2013 Aug; 173(2):323-31. PubMed ID: 23607908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
    Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
    Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
    Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qing Hua Chang Yin inhibits the LPS-induced activation of the IL-6/STAT3 signaling pathway in human intestinal Caco-2 cells.
    Ke X; Hu G; Fang W; Chen J; Zhang X; Yang C; Peng J; Chen Y; Sferra TJ
    Int J Mol Med; 2015 Apr; 35(4):1133-7. PubMed ID: 25633437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Interleukin-26 is upregulated in inflammatory bowel disease.
    Fujii M; Nishida A; Imaeda H; Ohno M; Nishino K; Sakai S; Inatomi O; Bamba S; Kawahara M; Shimizu T; Andoh A
    World J Gastroenterol; 2017 Aug; 23(30):5519-5529. PubMed ID: 28852311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease.
    Dambacher J; Beigel F; Seiderer J; Haller D; Göke B; Auernhammer CJ; Brand S
    Gut; 2007 Sep; 56(9):1257-65. PubMed ID: 17449633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of IL-11 expression in intestinal myofibroblasts: role of c-Jun AP-1- and MAPK-dependent pathways.
    Bamba S; Andoh A; Yasui H; Makino J; Kim S; Fujiyama Y
    Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G529-38. PubMed ID: 12760902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal subepithelial myofibroblasts in inflammatory bowel diseases.
    Andoh A; Fujino S; Okuno T; Fujiyama Y; Bamba T
    J Gastroenterol; 2002 Nov; 37 Suppl 14():33-7. PubMed ID: 12572863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.
    Sugihara T; Kobori A; Imaeda H; Tsujikawa T; Amagase K; Takeuchi K; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2010 Jun; 160(3):386-93. PubMed ID: 20089077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.
    Velikova T; Kyurkchiev D; Spassova Z; Karakolev I; Ivanova-Todorova E; Altankova I; Stanilova S
    Cytokine; 2017 Apr; 92():12-19. PubMed ID: 28088612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells.
    Bamias G; Filidou E; Goukos D; Valatas V; Arvanitidis K; Panagopoulou M; Kouklakis G; Daikos GL; Ladas SD; Kolios G
    Transl Res; 2017 Feb; 180():118-130.e2. PubMed ID: 27665176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
    Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
    Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease.
    Kusaka S; Nishida A; Takahashi K; Bamba S; Yasui H; Kawahara M; Inatomi O; Sugimoto M; Andoh A
    Clin Exp Immunol; 2018 Jan; 191(1):96-106. PubMed ID: 28872665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients.
    Gui X; Iacucci M; Ghosh S
    Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.